Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma

Clinical trial NCT06295159 · RECRUITING

Trial details

NCT number: NCT06295159
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma Stage III Melanoma Stage IV Advanced Melanoma Melanoma

Start date: 2024-05-17
Primary completion: 2028-11-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.